Showing results (371-380 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 13, 2012
SOCS1 is significantly up-regulated in Nutlin-3-treated p53wild-type B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155Maria Grazia di Iasio, Alessia Norcio, Elisabetta Melloni, et al.
Investigational New Drugs|January 10, 2012
Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits hepatocellular carcinoma in vitro and in vivo via stabilizing IkBαGeorge G Chen, Jackie Leung, Nian Ci Liang, et al.
Investigational New Drugs|December 16, 2011
Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulationKaouther Kolli-Bouhafs, Abdelaziz Boukhari, Abdurazzag Abusnina, et al.
Investigational New Drugs|January 11, 2012
Severe meningo-radiculo-neuritis associated with ipilimumabFlavie Bompaire, Christine Mateus, Hervé Taillia, et al.
Investigational New Drugs|March 28, 2012
Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agentMatthew Burge, Alessandra B Francesconi, Dusan Kotasek, et al.
Investigational New Drugs|February 24, 2012
Potential mucolytic agents for mucinous ascites from pseudomyxoma peritoneiKrishna Pillai, Javed Akhter, Terence C Chua, et al.
Investigational New Drugs|September 14, 2011
Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitorsYoshihiko Fujita, Rafiqul Islam, Kazuko Sakai, et al.
Investigational New Drugs|September 17, 2011
A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemiaCraig Reynolds, Nicholas Di Bella, Roger M Lyons, et al.
Investigational New Drugs|July 9, 2011
Feasibility and effectiveness of inhaled carboplatin in NSCLC patientsPaul Zarogoulidis, Ellada Eleftheriadou, Iordanis Sapardanis, et al.
Investigational New Drugs|October 4, 2011
Phase I dose-escalating study of panobinostat (LBH589) administered intravenously to Japanese patients with advanced solid tumorsSachi Morita, Satoshi Oizumi, Hironobu Minami, et al.
Pageof 372